Bone marrow transplantation for thalassemia

Early trials of allogeneic bone marrow transplantation (BMT) for homozygous beta-thalassemia and the analyses of results of transplantation in patients less then 16 years old have allowed us to identify three classes of risk using the criteria of degree of hepatomegaly, the degree of portal fibrosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucarelli, G., Angelucci, E., Giardini, C., Baronciani, D., Galimberti, M., Polchi, P., Erer, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 1993
Materias:
Symposium: Hematology/Oncology—II
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102227/
https://www.ncbi.nlm.nih.gov/pubmed/8262588
http://dx.doi.org/10.1007/BF02751428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102227/
https://www.ncbi.nlm.nih.gov/pubmed/8262588
http://dx.doi.org/10.1007/BF02751428

Ejemplares similares